Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2019-05-21 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
第二届监事会九次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 9th meeting of the 2nd Supervisory Board of Shenzhen BGI Genomics Co., Ltd. It details the approval of proposals related to the company's qualification and plan to publicly issue corporate bonds, including specifics on bond amount, issuance terms, use of proceeds, and related governance matters. The document includes voting results and states that the proposals will be submitted to the shareholders' meeting for further approval. It references the company's compliance with relevant laws and regulations and mentions that detailed bond issuance plans are published elsewhere. The document is an official meeting resolution announcement rather than a full financial report or detailed bond issuance document. It is not a full Annual Report, Interim Report, or Earnings Release. It is not a proxy solicitation or voting results declaration. It is not a regulatory filing of a different nature. The document is best classified as a Capital/Financing Update (CAP) because it concerns the company's financing activities and bond issuance plans approved by the supervisory board.
2019-05-21 Chinese
公司章程（2019年5月）
Governance Information Classification · 100% confidence The document is titled "深圳华大基因股份有限公司章程" which translates to "Articles of Association of Shenzhen BGI Genomics Co., Ltd." It contains detailed company bylaws including chapters on general provisions, business scope, share issuance, shareholders and shareholders' meetings, board of directors, senior management, supervisory board, financial accounting system, profit distribution, audit, notices and announcements, mergers, capital changes, dissolution, and amendments to the articles. The content is a comprehensive governance document outlining the company's internal rules, shareholder rights, board structure, and procedures. There is no indication that this is an announcement or a summary of a meeting, nor is it a financial report or audit report. It is a governance document that defines the company's organizational and operational framework. Therefore, the appropriate classification is Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the articles, not a brief announcement or notice.
2019-05-21 Chinese
关于召开2019年第三次临时股东大会的通知公告
AGM Information Classification · 95% confidence The document is a detailed notice and announcement for the 2019 third extraordinary general meeting (临时股东大会) of Shenzhen BGI Genomics Co., Ltd. It includes information about the meeting date, time, location, agenda items, voting procedures, and attachments such as proxy forms and shareholder registration forms. The agenda focuses on proposals related to the issuance of corporate bonds and amendments to the company's articles of association. The document is a formal meeting notice and does not contain financial statements, audit results, or management discussion and analysis. It is not a report or transcript but a notification to shareholders about the meeting and voting arrangements. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or other shareholder meetings.
2019-05-21 Chinese
第二届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the company's second board of directors' ninth meeting. It includes voting results, descriptions of agenda items such as approval for the company to issue bonds, authorization for the board to handle bond issuance details, amendments to the company bylaws, and scheduling of a shareholders' meeting. The document is not a full financial report but rather a formal announcement of board decisions and upcoming shareholder meeting arrangements. It does not contain financial statements or detailed financial analysis. The content fits the category of Board/Management Information (MANG), as it relates to board meeting resolutions and management decisions. The document length (5104 characters) and detailed content confirm it is not a brief announcement or a report publication notice. Therefore, the classification is MANG with high confidence.
2019-05-21 Chinese
公司债券发行预案
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company's plan to publicly issue corporate bonds, including the issuance plan, conditions, scale, use of proceeds, and authorization requests. It is not a financial report or earnings release but a capital raising update. The document length is 3625 characters, which is relatively short but contains substantive information about the financing plan rather than just announcing a report publication. The content focuses on bond issuance details, regulatory compliance, and shareholder authorization, fitting the Capital/Financing Update category.
2019-05-21 Chinese
2018年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as an announcement of the 2018 Annual General Meeting (AGM) resolutions of Shenzhen BGI Genomics Co., Ltd. It details the date, time, and location of the AGM, attendance statistics, voting results on various proposals including the 2018 annual report, board and supervisory reports, financial budget, profit distribution plan, auditor appointment, and other corporate matters. The document includes legal opinions on the validity of the meeting and voting procedures. The content is focused on the official announcement of the voting results and resolutions passed at the AGM, rather than the full annual report or financial statements themselves. The document length is about 5071 characters, which is consistent with a detailed announcement but not a full report. Therefore, this document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-05-21 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.